HC Wainwright cuts Ascendis Pharma target to $344
HC Wainwright & Co. cut its Ascendis Pharma price target to $344.00/share from $345.00.
Site Search
Search market news
Search SquawkNews news by ticker, company name or keyword.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
Showing 1 result for “HC Wainwright cuts Ascendis Pharma target to $344”, newest first.
Try again